Allergy Therapeutics is a Europe-based specialty pharmaceutical company focused upon the diagnosis and treatment of allergy. Allergy Therapeutics has an existing sales base of approximately £70 million per annum, an MHRA-approved manufacturing capability, as well as an established sales and marketing infrastructure in major European markets. In addition, the Company has a number of novel compounds which have already undergone initial clinical evaluation and, once registered, could potentially revolutionise the treatment of allergy.
If you'd like to be introduced to the team at Allergy Therapeutics plc, get in touch.
Request a meeting
